盘龙药业
(002864)
| 流通市值：20.94亿 | | | 总市值：30.08亿 |
| 流通股本：7398.46万 | | | 总股本：1.06亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,164,193,904.54 | 1,164,710,997.88 | 1,167,534,509.46 | 1,102,012,852.26 |
| 结算备付金 | - | - | - | 0 |
| 拆出资金 | - | - | - | 0 |
| 衍生金融资产 | - | - | - | 0 |
| 应收票据及应收账款 | 480,581,566.38 | 458,008,371.12 | 447,917,069.8 | 476,420,902.79 |
| 其中：应收票据 | 110,711,903.66 | 96,185,672.82 | 85,312,338.79 | 92,379,928.28 |
| 应收账款 | 369,869,662.72 | 361,822,698.3 | 362,604,731.01 | 384,040,974.51 |
| 应收款项融资 | - | - | - | 0 |
| 预付款项 | 17,732,497.48 | 13,688,000.74 | 8,001,485.15 | 17,175,667.69 |
| 应收保费 | - | - | - | 0 |
| 应收分保账款 | - | - | - | 0 |
| 应收分保合同准备金 | - | - | - | 0 |
| 其他应收款合计 | 1,660,821.46 | 2,185,634.88 | 1,272,171.23 | 3,070,200.26 |
| 应收股利 | - | - | - | 2,000,000 |
| 买入返售金融资产 | - | - | - | 0 |
| 存货 | 88,870,263.23 | 84,467,269.44 | 75,390,097.12 | 77,626,256.91 |
| 合同资产 | - | - | - | 0 |
| 一年内到期的非流动资产 | - | - | - | 0 |
| 其他流动资产 | 2,319,990.58 | 3,355,082.74 | 1,495,774.01 | 1,495,774.01 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,755,359,043.67 | 1,726,415,356.8 | 1,701,611,106.77 | 1,677,801,653.92 |
| 非流动资产: | | | | |
| 长期股权投资 | 9,539,081.7 | 9,593,380.96 | 9,658,861.7 | 9,710,670.72 |
| 固定资产 | 358,366,621.78 | 365,404,301.64 | 364,668,019.84 | 339,945,051.38 |
| 在建工程 | 65,937,662.39 | 50,478,124.32 | 44,838,725.85 | 29,310,951.57 |
| 使用权资产 | 2,516,199.9 | 2,616,847.9 | 2,357,095.84 | 2,444,395.69 |
| 无形资产 | 51,705,294.7 | 52,058,136.22 | 52,410,977.74 | 52,763,819.26 |
| 长期待摊费用 | 2,615,252.91 | 2,662,663.04 | 2,765,073.17 | 2,867,483.3 |
| 递延所得税资产 | 10,386,124.08 | 10,309,992.8 | 10,742,351.37 | 7,217,572 |
| 其他非流动资产 | 711,403.77 | 621,403.77 | 348,113.2 | 2,958,113.2 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 501,777,641.23 | 493,744,850.65 | 487,789,218.71 | 447,218,057.12 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,257,136,684.9 | 2,220,160,207.45 | 2,189,400,325.48 | 2,125,019,711.04 |
| 流动负债: | | | | |
| 短期借款 | 50,000,000 | 50,000,000 | 50,000,000 | 100,000,000 |
| 向中央银行借款 | - | - | - | 0 |
| 吸收存款及同业存放 | - | - | - | 0 |
| 拆入资金 | - | - | - | 0 |
| 交易性金融负债 | - | - | - | 0 |
| 衍生金融负债 | - | - | - | 0 |
| 应付票据及应付账款 | 97,472,292.33 | 93,189,478.19 | 83,706,703.84 | 91,431,680.45 |
| 其中：应付票据 | - | - | - | 0 |
| 应付账款 | 97,472,292.33 | 93,189,478.19 | 83,706,703.84 | 91,431,680.45 |
| 预收款项 | - | 355,596.33 | - | 355,596.33 |
| 合同负债 | 5,538,015.71 | 4,049,598.73 | 3,781,277.31 | 5,525,543.54 |
| 卖出回购金融资产款 | - | - | - | 0 |
| 应付手续费及佣金 | - | - | - | 0 |
| 应付职工薪酬 | 7,860,476.81 | 7,478,199.09 | 9,449,968.11 | 8,381,366.35 |
| 应交税费 | 21,532,542.89 | 17,896,883.64 | 16,238,993.55 | 20,989,743.59 |
| 其他应付款合计 | 264,023,066.53 | 269,926,854.72 | 244,979,827.09 | 252,858,246.68 |
| 应付分保账款 | - | - | - | 0 |
| 保险合同准备金 | - | - | - | 0 |
| 代理买卖证券款 | - | - | - | 0 |
| 代理承销证券款 | - | - | - | 0 |
| 一年内到期的非流动负债 | 370,949.12 | 370,949.12 | 756,396.54 | 386,158.39 |
| 其他流动负债 | 566,139.77 | 250,690.08 | 262,157.45 | 478,912.53 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 447,363,483.16 | 443,518,249.9 | 409,175,323.89 | 480,407,247.86 |
| 非流动负债: | | | | |
| 长期借款 | 99,500,000 | 100,000,000 | 100,000,000 | 0 |
| 应付债券 | - | - | - | 0 |
| 优先股 | - | - | - | 0 |
| 永续债 | - | - | - | 0 |
| 租赁负债 | 2,242,010.65 | 2,215,272.83 | 1,759,364.39 | 2,107,479.25 |
| 长期应付款 | - | - | - | 0 |
| 长期应付职工薪酬 | - | - | - | 0 |
| 预计负债 | - | - | - | 0 |
| 递延收益 | 98,793,994.54 | 95,786,188.49 | 95,540,132.41 | 91,245,770.53 |
| 递延所得税负债 | - | 427.49 | - | 0 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 200,536,005.19 | 198,001,888.81 | 197,299,496.8 | 93,353,249.78 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 647,899,488.35 | 641,520,138.71 | 606,474,820.69 | 573,760,497.64 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 106,280,960 | 106,280,960 | 106,280,960 | 106,280,960 |
| 资本公积 | 819,672,320.49 | 818,922,441.89 | 818,384,665.37 | 817,776,265.3 |
| 减:库存股 | 25,070,365.43 | 25,070,413.46 | 15,071,232 | 15,071,232 |
| 盈余公积 | 65,663,320.62 | 65,663,320.62 | 65,663,320.62 | 65,663,320.62 |
| 未分配利润 | 640,765,971.7 | 610,847,544.71 | 605,543,071.88 | 574,395,868.23 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,607,312,207.38 | 1,576,643,853.76 | 1,580,800,785.87 | 1,549,045,182.15 |
| 少数股东权益 | 1,924,989.17 | 1,996,214.98 | 2,124,718.92 | 2,214,031.25 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,609,237,196.55 | 1,578,640,068.74 | 1,582,925,504.79 | 1,551,259,213.4 |
| 负债和股东权益合计 | 2,257,136,684.9 | 2,220,160,207.45 | 2,189,400,325.48 | 2,125,019,711.04 |
| 公告日期 | 2024-10-28 | 2024-08-28 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |